Identification of lipopolysaccharide binding site on high molecular weight kininogen

Biochemical and Biophysical Research Communications

Volumn 366, Issue 4, 2008, Pages 938-943

  Perkins, R ^b   Ngo, M Dinh ^b   Mahdi, F ^a   Shariat Madar, Z ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

C1 inhibitor; High molecular weight kininogen (HK); Lipopolysaccharide (LPS); Prekallikrein (PK); Prolylcarboxypeptidase (PRCP)

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; COMPLEMENT COMPONENT C1S INHIBITOR; HEPARIN; HIGH MOLECULAR WEIGHT KININOGEN; LIPOPOLYSACCHARIDE; N ACETYLGLUCOSAMINE; NITRIC OXIDE; PLASMA KALLIKREIN; PLASMA KININ; PROSTACYCLIN;

ARTICLE; BINDING SITE; BLOOD FLOW; CELL CULTURE; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN CELL; IC 50; KALLIKREIN KININ SYSTEM; LIVER; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEPSIS; SEPTIC SHOCK;

BINDING SITES; BIOTIN; BIOTINYLATION; CARBOHYDRATES; CELLS, CULTURED; ENDOTHELIAL CELLS; HEPARIN; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; KININOGEN, HIGH-MOLECULAR-WEIGHT; LIPOPOLYSACCHARIDES; OSMOLAR CONCENTRATION; TIME FACTORS; UMBILICAL VEINS;

MACACA MULATTA; SALMONELLA TYPHIMURIUM;

EID: 37549026225     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.042     Document Type: Article

References (27)

1. Moreira C.R., Schmaier A.H., Mahdi F., da M.G., Nader H.B., and Shariat-Madar Z. Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator. FEBS Lett. 523 1-3 (2002) 167-170
2. Sharma J.N., and Al-Sherif G.J. Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists. ScientificWorldJournal 6 (2006) 1247-1261
3. Colman R.W., and Schmaier A.H. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90 10 (1997) 3819-3843
4. Shariat-Madar Z., and Schmaier A.H. Kininogen-cytokeratin 1 interactions in endothelial cell biology. Trends Cardiovasc. Med. 9 8 (1999) 238-244
5. Cerf M., Raidoo D., Fink E., Fritz H., and Bhoola K. Plasma kallikrein localisation in human blood vessels. Immunopharmacology 44 1-2 (1999) 75-80
6. Schmaier A.H., and McCrae K.R. The plasma Kallikrein/Kinin systems: its evolution from contact activation. J. Thromb. Haemost. (2007)
7. Ambuhl P., Felix D., Imboden H., Khosla M.C., and Ferrario C.M. Effects of angiotensin analogues and angiotensin receptor antagonists on paraventricular neurones. Regul. Pept. 38 2 (1992) 111-120
8. Shariat-Madar Z., and Schmaier A.H. The plasma kallikrein/kinin and renin angiotensin systems in blood pressure regulation in sepsis. J. Endotoxin Res. 10 1 (2004) 3
9. Iwaki T., and Castellino F.J. Plasma levels of bradykinin are suppressed in factor XII-deficient mice. Thromb. Haemost. 95 6 (2006) 1003-1010
10. Hooley E., McEwan P.A., and Emsley J. Molecular modelling of the prekallikrein structure provide insights into HK binding and zymogen activation. J. Thromb. Haemost. (2007)
11. Zhao Y., Qiu Q., Mahdi F., Shariat-Madar Z., Rojkjaer R., and Schmaier A.H. Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation. Am. J. Physiol. Heart Circ. Physiol. 280 4 (2001) H1821-H1829
12. Aasen A.O., and Wang J.E. Mediator responses in surgical infections. Surg. Infect. (Larchmt) 7 Suppl 2 (2006) S3-S4
13. Becker C.G., Wagner M., Kaplan A.P., Silverberg M., Grady R.W., Liem H., et al. Activation of factor XII-dependent pathways in human plasma by hematin and protoporphyrin. J. Clin. Invest. 76 2 (1985) 413-419
14. Fujita M., Izutani W., and Komurasaki Y. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats. Thromb. Haemost. 84 1 (2000) 54-58
15. Takano M., Horie M., Yayama K., and Okamoto H. Lipopolysaccharide injection into the cerebral ventricle evokes kininogen induction in the rat brain. Brain Res. 978 1-2 (2003) 72-82
16. Peake P.W., Shen Y., Campbell L.V., and Charlesworth J.A. Human adiponectin binds to bacterial lipopolysaccharide. Biochem. Biophys. Res. Commun. 341 1 (2006) 108-115
17. Mahdi F., Shariat-Madar Z., Kuo A., Carinato M., Cines D.B., and Schmaier A.H. Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor. J. Biol. Chem. 279 16 (2004) 16621-16628
18. Shariat-Madar Z., Mahdi F., and Schmaier A.H. Mapping binding domains of kininogens on endothelial cell cytokeratin 1. J. Biol. Chem. 274 11 (1999) 7137-7145
19. Pixley R.A., Lin Y., Isordia-Salas I., and Colman R.W. Fine mapping of the sequences in domain 5 of high molecular weight kininogen (HK) interacting with heparin and zinc. J. Thromb. Haemost. 1 8 (2003) 1791-1798
20. Croner R.S., Lehmann T.G., Fallsehr C., Herfarth C., Klar E., and Kirschfink M. C1-inhibitor reduces hepatic leukocyte-endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat. Microvasc. Res. 67 2 (2004) 182-191
21. Iarovaia G.A., Korovina N.A., and Magomedova M.P. The kallikrein-kinin system and blood plasma proteolysis inhibitors in various childhood nephropathies. Vopr. Med. Khim. 40 3 (1994) 16-18
22. D'Angelo A., la Valle P., Giudici D., and Vigano D.S. Protein C and coagulation in sepsis. Minerva Anestesiol. 70 5 (2004) 339-350
23. Shariat-Madar Z., Mahdi F., and Schmaier A.H. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J. Biol. Chem. 277 20 (2002) 17962-17969
24. Colman R.W. Biologic activities of the contact factors in vivo-potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis and thrombosis. Thromb. Haemost. 82 6 (1999) 1568-1577
25. Blais Jr. C., Couture R., Drapeau G., Colman R.W., and Adam A. Involvement of endogenous kinins in the pathogenesis of peptidoglycan-induced arthritis in the Lewis rat. Arthritis Rheum. 40 7 (1997) 1327-1333
26. Devani M., Cugno M., Vecchi M., Ferrero S., Di B.F., Avesani E.C., et al. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers. Am. J. Gastroenterol. 97 8 (2002) 2026-2032
27. Espinola R.G., Uknis A., Sainz I.M., Isordia-Salas I., Pixley R., DeLa C.R., et al. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis. Am. J. Pathol. 165 3 (2004) 969-976